| Name | Title | Contact Details |
|---|---|---|
Lisa Neal |
Vice President Compliance | Profile |
Allison Swartz |
General Counsel | Profile |
Bruce McCandless |
General Counsel | Profile |
To the scientific community, the name Harlan has meant high quality animals for over 70 years. Howard P. Harlan foresaw the need for laboratory animals and founded the business in Indianapolis, Indiana, in 1931. From 1931 until the time of his death in
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Kansas Health Solutions is a Topeka, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Midwest Medical Svc is a Charleston, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
California Vein is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.